Literature DB >> 11591378

Mechanisms mediating the antiproliferative effects of nitric oxide in cultured human airway smooth muscle cells.

A M Hamad1, A J Knox.   

Abstract

We have characterised the mechanisms involved in the antiproliferative effect of NO in human airway smooth muscle cells (HASMC). S-Nitroso-N-acetyl penicillamine, a nitric oxide donor, inhibited proliferation in both G(1) and S phases of the cell cycle. Additionally, experiments with 8-bromo-cGMP, haemoglobin, a NO scavenger and zaprinast, a cGMP-specific phosphodiesterase inhibitor, showed that both effects were NO-mediated. The G(1) phase inhibition was cGMP-dependent whereas the S phase inhibition was due to a cGMP-independent inhibition of ribonucleotide reductase. These results demonstrate that NO inhibits HASMC proliferation by cGMP-dependent and -independent mechanisms acting at distinct points in the cell cycle.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11591378     DOI: 10.1016/s0014-5793(01)02883-6

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  8 in total

Review 1.  Arginase: a key enzyme in the pathophysiology of allergic asthma opening novel therapeutic perspectives.

Authors:  Harm Maarsingh; Johan Zaagsma; Herman Meurs
Journal:  Br J Pharmacol       Date:  2009-08-24       Impact factor: 8.739

2.  Single-nucleotide promoter polymorphism alters transcription of neuronal nitric oxide synthase exon 1c in infantile hypertrophic pyloric stenosis.

Authors:  Dieter Saur; Jean-Marie Vanderwinden; Barbara Seidler; Roland M Schmid; Marc-Henri De Laet; Hans-Dieter Allescher
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-02       Impact factor: 11.205

3.  Nitric oxide-induced cellular stress and p53 activation in chronic inflammation.

Authors:  Lorne J Hofseth; Shin'ichi Saito; S Perwez Hussain; Michael G Espey; Katrina M Miranda; Yuzuru Araki; Chamelli Jhappan; Yuichiro Higashimoto; Peijun He; Steven P Linke; Martha M Quezado; Irit Zurer; Varda Rotter; David A Wink; Ettore Appella; Curtis C Harris
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-23       Impact factor: 11.205

4.  The cyclic GMP modulators YC-1 and zaprinast reduce vessel remodeling through antiproliferative and proapoptotic effects.

Authors:  Amit N Keswani; Kelly J Peyton; William Durante; Andrew I Schafer; David A Tulis
Journal:  J Cardiovasc Pharmacol Ther       Date:  2009-04-02       Impact factor: 2.457

5.  Arginase and arginine dysregulation in asthma.

Authors:  Renée C Benson; Karen A Hardy; Claudia R Morris
Journal:  J Allergy (Cairo)       Date:  2011-04-26

Review 6.  Nitric oxide and hyperoxic acute lung injury.

Authors:  Wen-Wu Liu; Cui-Hong Han; Pei-Xi Zhang; Juan Zheng; Kan Liu; Xue-Jun Sun
Journal:  Med Gas Res       Date:  2016-07-11

7.  Nitric oxide in asthma physiopathology.

Authors:  Carla M Prado; Mílton A Martins; Iolanda F L C Tibério
Journal:  ISRN Allergy       Date:  2011-04-19

Review 8.  Therapeutic potential of nitric oxide donors in the prevention and treatment of angiogenesis-inhibitor-induced hypertension.

Authors:  Peter Kruzliak; Gabriela Kovacova; Olga Pechanova
Journal:  Angiogenesis       Date:  2012-12-01       Impact factor: 9.596

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.